Kyverna Therapeutics, Inc (KYTX) insider trading
Every open-market stock purchase and sale by Kyverna Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $2M over the last 12 months (2 buys).
- Insiders sold $293K over the last 12 months (1 sale).
- Last insider buy: Beth C Seidenberg (Director), $1M, 9 months ago.
Last 12 months: insiders bought $2M (2 buys) and sold $293K (1 sale). Last close $7.47 on Jun 4, 2026.
Recent KYTX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| May 27, 2026 | Christi Shaw (Chair) | Sold (not open market) | $36K |
| May 27, 2026 | Fred E Cohen (Insider) | Bought (not open market) | — |
| May 27, 2026 | Mert Aktar (Insider) | Bought (not open market) | — |
| May 27, 2026 | Ian T Clark (Insider) | Bought (not open market) | — |
| May 27, 2026 | Ian T Clark (Insider) | Bought (not open market) | — |
| May 27, 2026 | Beth C Seidenberg (Insider) | Bought (not open market) | — |
| May 27, 2026 | Beth C Seidenberg (Insider) | Bought (not open market) | — |
| May 27, 2026 | Mert Aktar (Insider) | Bought (not open market) | — |
| May 27, 2026 | Fred E Cohen (Insider) | Bought (not open market) | — |
| May 18, 2026 | Gregory S. Martini (CFO) | Bought (not open market) | — |
| May 4, 2026 | Nadia Dac (C-suite exec) | Bought (not open market) | — |
| Mar 13, 2026 | Warner Weston Biddle (CEO) | Bought (not open market) | — |
| Mar 13, 2026 | Naji Gehchan (Insider) | Bought (not open market) | — |
| Mar 13, 2026 | Naji Gehchan (Insider) | Bought (not open market) | — |
| Mar 13, 2026 | Marc Grasso (CFO) | Bought (not open market) | — |
| Mar 13, 2026 | Marc Grasso (CFO) | Bought (not open market) | — |
| Mar 13, 2026 | Warner Weston Biddle (CEO) | Bought (not open market) | — |
| Feb 24, 2026 | Sravan Kumar Emany (Insider) | Bought (not open market) | — |
| Feb 24, 2026 | Andrew Craig Miller (Insider) | Bought (not open market) | — |
| Feb 24, 2026 | Andrew Craig Miller (Insider) | Bought (not open market) | — |
| Feb 24, 2026 | Sravan Kumar Emany (Insider) | Bought (not open market) | — |
| Feb 9, 2026 | Mayobanex Pujols (CTO) | Bought (not open market) | — |
| Jan 12, 2026 | Christi Shaw (Chair) | Bought (not open market) | — |
| Jan 12, 2026 | Christi Shaw (Chair) | Bought (not open market) | — |
| Jan 12, 2026 | Christi Shaw (Chair) | Bought (not open market) | — |
Who's trading KYTX
- Mert Aktar, Insider: other filings, last May 27, 2026
- Christi Shaw, Chair: other filings, last May 27, 2026
- Beth C Seidenberg, Insider: bought $1M (1 buy), last May 27, 2026
- Ian T Clark, Insider: other filings, last May 27, 2026
- Fred E Cohen, Insider: other filings, last May 27, 2026
- Gregory S. Martini, CFO: other filings, last May 18, 2026
- Nadia Dac, C-suite exec: other filings, last May 4, 2026
- Naji Gehchan, Insider: other filings, last Mar 13, 2026
- Warner Weston Biddle, CEO: other filings, last Mar 13, 2026
- Marc Grasso, CFO: other filings, last Mar 13, 2026
- Andrew Craig Miller, Insider: other filings, last Feb 24, 2026
- Sravan Kumar Emany, Insider: other filings, last Feb 24, 2026
- Mayobanex Pujols, CTO: other filings, last Feb 9, 2026
- Westlake BioPartners Opportunity Fund I L.P., 10% owner: bought $1M (1 buy), last Dec 18, 2025
- Karen Marie Walker, CTO: sold $293K (1 sale), last Dec 15, 2025
Get free alerts when an insider at Kyverna Therapeutics, Inc files a new trade →